A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas
Dren Bio
Dren Bio
Curis, Inc.
Incyte Corporation
AVM Biotechnology Inc
Bristol-Myers Squibb
AvenCell Therapeutics, Inc.
Vironexis Biotherapeutics Inc.
Sellas Life Sciences Group
National Institutes of Health Clinical Center (CC)
Allogene Therapeutics
University of Chicago
Penn State University
Ossium Health, Inc.
National Institutes of Health Clinical Center (CC)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Seattle Children's Hospital
Essen Biotech
SymBio Pharmaceuticals
Sheba Medical Center
UNC Lineberger Comprehensive Cancer Center
Dana-Farber Cancer Institute
Institute of Hematology & Blood Diseases Hospital, China
Memorial Sloan Kettering Cancer Center
CRISPR Therapeutics
CRISPR Therapeutics
Incyte Corporation
National Institutes of Health Clinical Center (CC)
Biotroy Therapeutics
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
Princess Maxima Center for Pediatric Oncology
Tianjin Medical University General Hospital
Affiliated Hospital to Academy of Military Medical Sciences
Beam Therapeutics Inc.
University of Sao Paulo
Takeda
Columbia University
Celgene
Columbia University
Altor BioScience
Columbia University
City of Hope Medical Center
University Hospital, Basel, Switzerland
University of Nebraska
Celgene
University of Nebraska
Telios Pharma, Inc.
920th Hospital of Joint Logistics Support Force of People's Liberation Army of China
Asana BioSciences
Chongqing Precision Biotech Co., Ltd
Chongqing Precision Biotech Co., Ltd